Filana TherapeuticsFLNA
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Filana Therapeutics Inc. (FLNA) in their 13F filings. The largest holder was Tanaka Capital Management Inc. ($0).
- Company
- Filana Therapeutics Inc.
- Filed as
- Fuelnation, Inc. (Q1 2024)
- CUSIP
- 359528205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Tanaka Capital Management Inc. | 0.00% | No change | 251,150 | $0 |
"% of holder's portfolio" is FLNA's weight in each manager's 13F, not the share of Filana Therapeutics Inc. the manager owns.